Myriad Genetics Moves into Oversold Territory – Zacks Tale of the Tape
Source: http://www.zacks.com/stock/news/19510/Myriad+Genetics+Moves+into+Oversold+Territory+-+Zacks+Tale+of+the+TapePosted on Friday, April 24th, 2009 | In Market Commentary, Stocks to Watch
Contributed by: Zacks Market Commentaries (http://www.zacks.com/) -
Myriad Genetics Inc’s (MYGN) share price has entered into oversold territory with a stochastic value of 14.75. The Zacks #2 Rank (“Buy”) stock has either met or topped the consensus estimate in each of the last 4 quarters with an average surprise of 275.68%, or 32 cents per share. Moreover, analysts have been increasing their full-year earnings estimates, with the consensus up 8 cents over the past 30 days to 93 cents per share.
Last 5 posts by Zacks Market Commentaries
- Steel Dynamics Raises Debt - Analyst Blog - March 19th, 2010
- DuPont Focus on Plant Genetics - Analyst Blog - March 19th, 2010
- Ford Receives Grants - Analyst Blog - March 19th, 2010
- HD to roll out Spring Black Friday - Analyst Blog - March 19th, 2010
- PPL Awards $70M Contract, Builds Jobs - Analyst Blog - March 19th, 2010
 About Zacks Market Commentaries (http://www.zacks.com/)
Zacks Market Commentaries |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.